Identity has acquired Coda, a specialist healthcare communications agency.
The partnership creates IdentityCoda, strengthening Identity’s ability to support pharmaceutical and healthcare organisations with compliant, high-impact events and experiences across global markets.
Founded in 2015, Coda has built a reputation for delivering technical excellence and creative clarity across global healthcare meetings, congress programmes, and hybrid experiences. Trusted by some of the world’s top pharmaceutical companies, the agency transforms complex science into engaging experiences that unite audiences and drive understanding, delivering over 100 programmes annually.
Supporting healthcare innovation
Olivier Vallee, CEO of Identity, said: “Advancement in healthcare is vital for us all. The organisations developing treatments, conducting research, and pushing scientific boundaries deserve environments where their expertise can shine. Bringing Coda into Identity gives us the privilege of supporting that mission with deeper capability and broader reach.
“We’re in the Golden Age of Experience, and the rate of change is accelerating. IdentityCoda will continue to operate with the specialist focus and expertise clients trust, now enhanced by Identity’s global infrastructure, complementary capabilities, and resources. Together, we can deliver more for healthcare organisations navigating increasingly complex communication challenges.”
Enhanced capability, maintained focus
Mark Owen, Director at IdentityCoda, said: “Joining Identity strengthens our ability to serve pharmaceutical clients at scale while maintaining the specialist expertise and personal attention that defines how we work. Access to Identity’s technical innovation, creative talent, and global delivery network means we can support more ambitious programmes without compromising the precision and compliance healthcare communications demand.”
Rob Murdoch, Director at IdentityCoda, added: “Healthcare organisations operate in highly regulated environments where scientific integrity, compliance, and stakeholder confidence are non-negotiable. IdentityCoda combines deep understanding of these requirements with decades of global delivery experience. Now, as part of Identity, we further strengthen our capability across live, hybrid, and digital healthcare experiences.”
Delivering healthcare experiences at scale
The acquisition responds to growing demand from pharmaceutical organisations for integrated experience partners capable of delivering complex, compliant programmes at global scale. IdentityCoda clients benefit from immediate access to Identity’s expanded creative, technical, and production resources, further strengthening healthcare event delivery worldwide.
Michael Gietzen, Group CEO, said: “Experience plays a critical role in healthcare communication, transforming complex science into moments that engage, educate, and inspire action. Over the last three years, Identity has built formidable strength in strategy, creativity, content production, and global delivery infrastructure. That foundation positions IdentityCoda to become a major international force in healthcare events, benefiting from our work at the forefront of innovation with challenger brands worldwide.”
Comprehensive healthcare experience solutions
IdentityCoda delivers end-to-end support for pharmaceutical and healthcare communications, including:
- Congress programmes and satellite symposia
- Investigator meetings and advisory boards
- Leadership programmes and internal communications
- Exhibition design and brand experiences
- Hybrid and virtual healthcare events
- Content production and scientific storytelling
- Strategic consultancy and compliance oversight
The agency operates from offices in Cheshire, UK, and Coimbra, Portugal, supporting clients across Europe, North America, Middle East and global markets.
IdentityCoda’s new website can be viewed here: www.identitycoda.com
Follow IdentityCoda on Linkedin here: IdentityCoda
